Zacks Investment Research
30 Jul 2026, 01:36 UTC · 2h ago
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
30 Jul 2026, 01:36 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Core Laboratories reported quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. — An earnings beat typically provides a positive short-term catalyst for the stock price.
+0.30Core Laboratories currently holds a Zacks Rank #4 (Sell) due to an unfavorable trend in earnings estimate revisions. — A 'Sell' rank based on downward estimate revisions indicates a negative medium-term outlook for the stock.
-0.30Core Laboratories reported quarterly revenues of $124.61 million, missing the Zacks Consensus Estimate by 2.31%. — Revenue misses suggest slowing growth or demand, which can offset the positivity of an earnings beat.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Core Laboratories shares have declined approximately 33.3% since the beginning of the year, significantly underperforming the S&P 500. — Strong negative price momentum often reflects broader fundamental weaknesses or lack of investor confidence.
Which stocks this story touches
The company beat earnings estimates but missed revenue estimates and carries a Zacks Rank #4 (Sell) rating.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Zacks Investment Research
54m ago
